These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10708101

  • 1. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.
    Viklický O, Zou H, Müller V, Lacha J, Szabó A, Heemann U.
    Transplantation; 2000 Feb 27; 69(4):497-502. PubMed ID: 10708101
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of 40-O-(2-hydroxyethyl)-rapamycin in preventing chronic renal allograft rejection in rats].
    Zou H, Bai J, Lai D.
    Zhonghua Nei Ke Za Zhi; 1999 Dec 27; 38(12):810-3. PubMed ID: 11798722
    [Abstract] [Full Text] [Related]

  • 3. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
    Hausen B, Boeke K, Berry GJ, Segarra IT, Christians U, Morris RE.
    J Heart Lung Transplant; 1999 Feb 27; 18(2):150-9. PubMed ID: 10194039
    [Abstract] [Full Text] [Related]

  • 4. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo.
    Schuler W, Sedrani R, Cottens S, Häberlin B, Schulz M, Schuurman HJ, Zenke G, Zerwes HG, Schreier MH.
    Transplantation; 1997 Jul 15; 64(1):36-42. PubMed ID: 9233698
    [Abstract] [Full Text] [Related]

  • 5. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ, Ringers J, Schuler W, Slingerland W, Jonker M.
    Transplantation; 2000 Mar 15; 69(5):737-42. PubMed ID: 10755519
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
    Hausen B, Boeke K, Berry GJ, Christians U, Schüler W, Morris RE.
    Ann Thorac Surg; 2000 Mar 15; 69(3):904-9. PubMed ID: 10750781
    [Abstract] [Full Text] [Related]

  • 7. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B, Gummert J, Berry GJ, Christians U, Serkova N, Ikonen T, Hook L, Legay F, Schuler W, Schreier MH, Morris RE.
    Transplantation; 2000 Feb 27; 69(4):488-96. PubMed ID: 10708100
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine A and azathioprine are equipotent in chronic kidney allograft rejection.
    Hamar P, Liu S, Viklický O, Szabó A, Múller V, Heemann U.
    Transplantation; 2000 Apr 15; 69(7):1290-5. PubMed ID: 10798743
    [Abstract] [Full Text] [Related]

  • 9. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U.
    Kidney Int; 2000 Mar 15; 57(3):982-91. PubMed ID: 10720951
    [Abstract] [Full Text] [Related]

  • 10. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B, Ikonen T, Briffa N, Berry GJ, Christians U, Robbins RC, Hook L, Serkova N, Benet LZ, Schuler W, Morris RE.
    Transplantation; 2000 Jan 15; 69(1):76-86. PubMed ID: 10653384
    [Abstract] [Full Text] [Related]

  • 11. Early clinical experience with a novel rapamycin derivative.
    Nashan B.
    Ther Drug Monit; 2002 Feb 15; 24(1):53-8. PubMed ID: 11805723
    [Abstract] [Full Text] [Related]

  • 12. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH.
    Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186
    [Abstract] [Full Text] [Related]

  • 13. RAD reduces compensatory renal graft hypertrophy in a rat model of chronic rejection.
    Viklický O, Müller V, Zou H, Szabó A, Vitko S, Heemann U.
    Transplant Proc; 2001 May 27; 33(3):2320-1. PubMed ID: 11377546
    [No Abstract] [Full Text] [Related]

  • 14. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts.
    Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL.
    Transplantation; 1995 Feb 27; 59(4):460-6. PubMed ID: 7878746
    [Abstract] [Full Text] [Related]

  • 15. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H.
    Transplantation; 2003 Jan 15; 75(1):54-9. PubMed ID: 12544871
    [Abstract] [Full Text] [Related]

  • 16. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
    Schuurman HJ, Cottens S, Fuchs S, Joergensen J, Meerloo T, Sedrani R, Tanner M, Zenke G, Schuler W.
    Transplantation; 1997 Jul 15; 64(1):32-5. PubMed ID: 9233697
    [Abstract] [Full Text] [Related]

  • 17. Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection.
    Reis A, Megahed M, Reinhard T, Godehardt E, Braunstein C, Sundmacher R.
    Cornea; 2002 Jan 15; 21(1):81-4. PubMed ID: 11805513
    [Abstract] [Full Text] [Related]

  • 18. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
    Hausen B, Boeke K, Berry GJ, Segarra I, Benet LZ, Christians U, Morris RE.
    Transplantation; 1999 Apr 15; 67(7):956-62. PubMed ID: 10221478
    [Abstract] [Full Text] [Related]

  • 19. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12439-44. PubMed ID: 8901600
    [Abstract] [Full Text] [Related]

  • 20. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 29; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.